Browsing Tag
Goldman Sachs
95 posts
Goldman Sachs smashes Q1 estimates with $4.74bn profit as equities, FICC deals surge
Goldman Sachs delivered $4.74B in Q1 profit with strong earnings from equities, FICC, and debt underwriting. Find out what drove the gains this quarter.
SolarWinds goes private in $4.4bn deal as Turn/River bets big on AI-powered IT resilience
Turn/River acquires SolarWinds in a $4.4B deal, taking it private to boost observability, AI-driven IT tools, and hybrid cloud innovation—read more.
Trump’s new tariffs send oil prices crashing to 2021 lows—global fuel demand in jeopardy?
Find out how Trump’s latest tariffs are shaking global oil markets and threatening demand—Brent and WTI hit multi-year lows amid trade war escalation.
Can AI finally solve financial risk decisioning? Taktile secures $54m to make it happen
Taktile, a leader in AI-driven risk decisioning, has raised $54 million in a Series B funding round, reinforcing…
SolarWinds to go private after $4.4bn acquisition by Turn/River Capital
In a significant move within the technology sector, SolarWinds Corporation, a leading provider of IT management software, has…
Emerson’s $265 per share tender offer signals strategic move to acquire full control of AspenTech
Emerson has formally launched its tender offer to acquire all remaining shares of Aspen Technology, Inc. (AspenTech) that…
Goldman Sachs delivers robust 2024 earnings with record growth in key segments
Goldman Sachs Group, Inc. (NYSE: GS) showcased an impressive financial performance for 2024, reporting net revenues of $53.51…
Goldman Sachs doubles down on blockchain—spinning out GS DAP for massive growth
Goldman Sachs is set to spin out its blockchain-powered platform, GS Digital Assets Platform (GS DAP), within the…
J.M. Smucker to offload Voortman in stunning $305m move—What’s next for the iconic brand?
J.M. Smucker Company, a leading American food manufacturer, has announced the sale of its cookie brand, Voortman, to…
Sanofi enters exclusive talks with CD&R over $17bn Opella deal
Sanofi has confirmed its exclusive negotiations with Clayton, Dubilier & Rice (CD&R) for the sale of a 50%…